Inhibikase Therapeutics plans participation in Jefferies and Evercore healthcare conferences
IKT•Inhibikase Therapeutics will attend healthcare conferences in London on Nov. 16-19 and Coral Gables, Florida, on Nov. 30-Dec. 2, 2026. CEO Mark Iwicki is scheduled for a Nov. 16 fireside chat, and the company will hold one-on-one meetings at both events.
1. Conference schedule
Inhibikase Therapeutics will attend the Jefferies Global Healthcare Conference in London Nov. 16-19, 2026. CEO Mark Iwicki will join Jefferies Research’s Dennis Ding for a fireside chat on Nov. 16 at 3 p.m. GMT, and management will hold one-on-one meetings Nov. 16-17.
2. Evercore conference
The company will also attend the 9th Annual Evercore Healthcare Conference in Coral Gables, Florida, Nov. 30-Dec. 2, 2026, with one-on-one meetings scheduled for Dec. 1.
